Subgaleal hemorrhage medical therapy

Subgaleal Hemorrhage Microchapters
Home
Patient Information
Overview
Anatomy
Historical Perspective
Pathophysiology
Causes
Differentiating Subgaleal Hemorrhage from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Subgaleal hemorrhage medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Subgaleal hemorrhage medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Subgaleal hemorrhage medical therapy
CDC on Subgaleal hemorrhage medical therapy
Subgaleal hemorrhage medical therapy in the news
Blogs on Subgaleal hemorrhage medical therapy
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Subgaleal hemorrhage medical therapy

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Management consists of vigilant observation over days to detect progression. Fluid bolus may be required if blood loss is significant and patient becomes tachycardic. Transfusion and phototherapy may be necessary. Investigation for coagulopathy may be indicated.

References

Template:WikiDoc Sources